Full text 
Procedure : 2008/0045(COD)
Document stages in plenary
Document selected : A6-0346/2008

Texts tabled :


Debates :

PV 22/10/2008 - 2
CRE 22/10/2008 - 2

Votes :

PV 22/10/2008 - 4.6
Explanations of votes
Explanations of votes

Texts adopted :


Wednesday, 22 October 2008 - Strasbourg

2. Variations to the terms of marketing authorisations for medicinal products ***I - Counterfeiting of medicinal products (debate)
Verbatim reports

Report: on the proposal for a directive of the European Parliament and of the Council amending Directive 2001/82/EC and Directive 2001/83/EC as regards variations to the terms of marketing authorisations for medicinal products [COM(2008)0123 - C6-0137/2008 - 2008/0045(COD)] - Committee on the Environment, Public Health and Food Safety. Rapporteur: Françoise Grossetête (A6-0346/2008)

Commission statement: Counterfeiting of medicinal products

Françoise Grossetête introduced the report.

Günter Verheugen (Vice-President of the Commission) made the statement.

The following spoke: Petya Stavreva (draftsman of the opinion of the AGRI Committee), Cristina Gutiérrez-Cortines, on behalf of the PPE-DE Group, Dagmar Roth-Behrendt, on behalf of the PSE Group, Alessandro Foglietta, on behalf of the UEN Group, Jiří Maštálka, on behalf of the GUE/NGL Group, Kathy Sinnott, on behalf of the IND/DEM Group, Irena Belohorská, Non-attached Member, Eija-Riitta Korhola, Daciana Octavia Sârbu, Marios Matsakis, Hanne Dahl, Zuzana Roithová, Giovanna Corda, Thomas Ulmer, Genowefa Grabowska, Cristian Silviu Buşoi and Amalia Sartori.

The following spoke under the 'catch-the-eye' procedure: Miroslav Mikolášik, Dagmar Roth-Behrendt, Jorgo Chatzimarkakis, Dumitru Oprea, Donato Tommaso Veraldi and Emmanouil Angelakas.

The following spoke: Günter Verheugen and Françoise Grossetête.

The debate closed.

Vote: minutes of 22.10.2008, item 4.6.

Legal notice - Privacy policy